Switch to:
More From Other Websites
CYTRX CORP Financials Aug 19 2014
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into CytRx... Aug 11 2014
Oral Presentation of CytRx’s Aldoxorubicin Phase 2b Clinical Trial in Soft Tissue Sarcoma... Aug 07 2014
Oral Presentation of CytRx’s Aldoxorubicin Phase 2b Clinical Trial in Soft Tissue Sarcoma... Aug 07 2014
CytRx Reports 2014 Second Quarter Financial Results Aug 06 2014
CYTRX CORP Files SEC form 10-Q, Quarterly Report Aug 06 2014
CYTRX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 06 2014
CytRx Reports 2014 Second Quarter Financial Results Aug 06 2014
Former Louisiana Attorney General and KSF Announce Appointment as Lead Counsel in CytRx Securities... Aug 05 2014
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into CytRx... Jul 09 2014
CytRx Added to Russell 3000® and Russell 2000® Indexes Jun 30 2014
CYTRX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 27 2014
Five Analyst Stock Picks With 100% or More Implied Upside Jun 07 2014
Celldex: The Race Leader In Glioblastoma Multiforme May 29 2014
CytRx to Present at the Jefferies 2014 Global Healthcare Conference May 29 2014
CytRx's aldoxorubicin for sarcoma shows positive Phase 2b results May 28 2014
CytRx Highlights Aldoxorubicin Data from its Global Phase 2b Clinical Trial in First-Line Soft... May 28 2014
CYTRX 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and... May 09 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide